Breast cancer affects Iranian women at least one decade younger than their counterparts in othercountries and the incidence of breast fibroadenoma is growing in the last two decades in Tehran. Thisstudy aimed to compare the AhR levels in premenopausal breast cancer and breast fibroadnemo withappropriate normal groups. Possible associations of AhR with lifestyle and reproductive risk factorsand ...

Objectives: PCOS is an endocrine disorder that common in women. However, effects on oral and dental health have not been stated clearly. The aim of this study to examine the Polycystic Ovary Syndrome (PCOS), which women reproductive age, saliva tissues these women.
 Materials Methods: One-hundred individuals who were / diagnosed with insulin resistance included (n=100). Subsequently, indiv...

Polycystic ovary syndrome (PCOS) is a highly prevalent disorder, representing the single most common endocrine-metabolic disorder in reproductive-aged women. Our aim was to determine annual health insurance treatment cost of polycystic Hungary. Data were derived from financial database Hungarian National Health Insurance Fund Administration year 2019. The included costs, number patients and fin...

Abstract Background Polycystic ovary syndrome (PCOS) is a common endocrine–metabolic disorder due to genetic and environmental factors. Genetic variants located in intron 1 of Fat mass obesity-associated ( FTO ) gene are associated with increased risk obesity metabolic disorders. This study aims investigate the association polymorphism rs9939609 South Indian women PCOS assess its endocrine para...

Polycystic ovary syndrome (POS) is one of the most common endocrine abnormalities affecting women of reproductive age. It is a cause of significant social embarrassment and emotional distress. The pathogenesis of the disease is not yet fully understood, but it is thought to be a complex multigenic disorder, including abnormalities in the hypothalamic-pituitary axis, steroidogenesis, and insulin...

objective: polycystic ovary syndrome (pcos) is one of the most common endocrine disorders that is associated with different metabolic, reproductive and psychological consequences. the main aim of this study was to compare the sexual function and quality of life in women with polycystic ovary syndrome and healthy women. materials and methods: this is a causal-comparative study in which 129 women...

Luteinizing hormone-releasing hormone analogs (LHRHa) are often used alone or in combination with tamoxifen to suppress ovarian function in premenopausal women with endocrine-responsive breast cancer. However, aromatase inhitiors (AIs) are now the preferred first-line endocrine treatment for postmenopausal women with breast cancer. Their benefits over tamoxifen in postmenopausal patients and th...

Polycystic ovary syndrome (PCOS) is an endocrine disorder and metabolic syndrome. Ovarian fibrosis pathological change in PCOS has gradually attracted people’s attention. In this study, we constructed a mouse model through the use of dehydroepiandrosterone. Sirius red staining showed that ovarian tissues mice had obvious fibrosis. Prolyl oligopeptidase (POP) serine protease N-acetyl-seryl-aspar...

OBJECTIVE — Increased serum ferritin levels and iron stores may be involved in the development of abnormal glucose tolerance in women presenting with obesity and/or polycystic ovary syndrome (PCOS). We aimed to study the determinants of serum ferritin levels in premenopausal women among indexes of insulin resistance, adiposity, hyperandrogenism, and genotypes pertaining to inflammation, oxidati...